Testosterone therapy can modestly improve mood in some men who have confirmed, clinically low testosterone. It is not a proven treatment for depression, and it is not a replacement for depression care. The best trials show small average gains, and the benefit looks strongest in carefully selected men: those with truly low levels, and in some studies those with mild depressive symptoms. This guide explains what the research found, who it applies to, and what to ask a clinician. It is general education, not medical advice.
TL;DR
- Low testosterone is linked to depression and low mood, but a link does not prove that low testosterone causes the mood problem.
- In large trials of men with confirmed low levels, testosterone therapy gave modest average mood improvements. Results vary a lot from person to person.
- Testosterone is a complementary approach at best. Depression itself needs its own evaluation and treatment.
- Diagnosis needs symptoms plus two consistently low morning blood tests, and treatment needs ongoing monitoring by a clinician.
- Treatment decisions belong to a qualified clinician who knows your history.
Table of Contents
- Low testosterone and depression: what the link shows
- Does testosterone therapy improve mood?
- Who might see a mood benefit, and who might not
- How soon could mood change?
- How clinicians confirm low testosterone
- Safety and who should not start
- What about women?
- Preparing for a consultation
- Our perspective
- Taking the next step
- FAQ
- Sources
Low testosterone and depression: what the link shows
Mood and testosterone are connected in the data, but the connection is looser than marketing often suggests.
In a 2008 study of 3,987 older men in Australia, those in the lowest fifth for free testosterone had about three times the odds of depression compared with those in the highest fifth (odds ratio 3.12). The association held after the researchers adjusted for age, education, smoking, body mass index, cognitive impairment and physical health. The authors raised the possibility of a causal relationship in elderly men. A study of this design can only show association.
Later reviews are more cautious. A review of testosterone and mood in men concluded that low testosterone is related to depressive disorders in certain subpopulations, but that the evidence is insufficient to say it routinely leads to major depressive disorder. A 2022 review found that levels low enough to meet strict criteria for hypogonadism go along with higher depression risk and more current symptoms. It also said the benefit of testosterone therapy for men with major depressive disorder and low testosterone remains uncertain.
The link also runs in several directions at once. Poor sleep, excess weight, chronic illness, alcohol use and stress can lower testosterone and worsen mood. Depression itself can reduce energy and sex drive, which are also classic low testosterone symptoms. That overlap is why symptoms alone cannot tell you the cause.

Does testosterone therapy improve mood?
The short answer from randomized trials: a little, on average, in men who truly have low levels.
The largest trials
The TRAVERSE trial randomized 5,204 men aged 45 to 80 with two fasting testosterone levels under 300 ng/dL. About half (50.8%) had significant depressive symptoms at the start, yet only 1.5% met strict criteria for a persistent depressive disorder. Testosterone treatment was associated with modest but significantly greater improvements in mood and energy. It did not improve cognition or sleep quality.
The Testosterone Trials in men 65 and older found that raising levels for one year from moderately low to mid-normal gave some benefit for mood and depressive symptoms, a moderate benefit for sexual function, and no benefit for vitality or walking distance. A later review of those trials described the mood effect as small, and suggested this might relate to how modestly low testosterone was in the participants.
Pooled analyses
A 2019 meta-analysis of 27 randomized trials with 1,890 men found that testosterone was associated with a significant reduction in depressive symptoms compared with placebo (Hedges g 0.21). That is a small effect. The benefit was seen particularly with higher-dose regimens in carefully selected samples.
A 2017 network meta-analysis found that testosterone therapy as a class improved depression scores, though no single product was significantly better than placebo on its own. A 2020 systematic review of 15 studies concluded that therapy reduced depressive symptoms in men with late-onset testosterone deficiency and mild depression before treatment, but this was not seen in men with major depressive disorder.
Not every expert reads the evidence the same way
The American College of Physicians guidance, summarized by the American Family Physician, said testosterone failed to show clinically significant improvement in fatigue and depressive symptoms in older men with age-related low testosterone. It suggested not using it to improve energy, vitality, physical function or cognition. This is one reason clinicians talk about testosterone for mood in terms of selected patients rather than everyone with a low number.
Put together, a fair summary looks like this:
| Question | What the evidence suggests |
|---|---|
| Does it help men with confirmed low levels? | Modest average mood gains in large trials |
| Does it treat major depressive disorder alone? | Mixed or not shown in men with major depression |
| Does it help energy and vitality? | Inconsistent across trials |
| Does it help sexual function? | More consistent than mood in the Testosterone Trials |
| Is it a first-line depression treatment? | No, at most a complementary approach |
Who might see a mood benefit, and who might not
The research points to a few patterns, and each one is a reason to talk with a clinician instead of guessing.
- Men with unequivocally low, confirmed levels. Benefits in the trials were observed in men with documented low testosterone, not in men with normal levels.
- Men with mild depressive symptoms. The 2020 review found the effect in mild cases, not in major depressive disorder.
- Selected special groups. A review of testosterone and depression in men found no consistent relationship between level and mood overall, but suggested testosterone may work in carefully selected groups, including hypogonadal men and men whose depression did not respond to antidepressants.
- Treatment-resistant depression. A 2026 systematic review of 11 trials with over 600 men found significant improvement in men with treatment-resistant depression, while trials in hypogonadal men with major depressive disorder gave mixed results, likely because of high placebo response. Its authors framed testosterone as complementary, not primary, and under endocrinological supervision. One practical read of that: if you are already seeing a mental health professional, testosterone is a topic to raise with them and an endocrine-minded clinician together. For more on this use, see this overview of testosterone as adjunct depression treatment.
What the evidence does not support is using testosterone to treat a normal level. If your total testosterone is in the normal range, no trial here shows that adding more improves mood.
How soon could mood change?
The honest answer is that it is not predictable. The trials above measured mood at fixed points, often months in, and the Testosterone Trials ran for a year. They report average group changes, not a timeline you can count on for one person. Some online guides give tidy week-by-week schedules, but the trials do not support promising a specific date.
What clinicians generally do is set a follow-up plan: recheck levels, review symptoms with a standard questionnaire, and decide together whether the treatment is helping. If your mood is getting worse at any point, that is a reason to call your clinician or a mental health professional promptly, not to wait for the next scheduled visit. If you are having thoughts of harming yourself, call or text 988, the Suicide and Crisis Lifeline, in the US.
How clinicians confirm low testosterone
The Endocrine Society guideline recommends diagnosing hypogonadism only in men who have symptoms and signs consistent with testosterone deficiency and unequivocally, consistently low testosterone. The test should be total testosterone measured in the morning, fasting, with a reliable assay, and the result should be confirmed by a repeat measurement.
In practice, that means:
- A symptom review. Low mood, low libido, fatigue, erectile changes, reduced muscle mass and poor sleep are all discussed, along with other possible causes.
- Two morning blood draws. A single low reading is not enough. Our article on why two morning tests matter goes through this in more detail.
- A check for other contributors. Sleep apnea, medications, thyroid issues, depression and anxiety, and weight all deserve a look.
- A risk screen before any treatment. See the next section.
Safety and who should not start
The same Endocrine Society guideline recommends against starting testosterone therapy in men who are planning fertility in the near term, or who have breast or prostate cancer, a palpable prostate nodule, PSA above 4 ng/mL (or above 3 ng/mL in men at higher prostate cancer risk without urological evaluation), elevated hematocrit, untreated severe obstructive sleep apnea, severe lower urinary tract symptoms, uncontrolled heart failure, a heart attack or stroke within six months, or thrombophilia.
On regulation, the FDA states that prescription testosterone products are approved only for men with low levels from certain medical conditions, and that benefit and safety have not been established for low levels due only to aging. The FDA also required labeling about a possible increased risk of heart attack and stroke. Depression is not an approved reason to take testosterone.
The 2026 systematic review reported that across its trials, therapy was well tolerated, with mild edema (under 5%), injection-site reactions (under 4%) and acne (under 3%) being the minor effects. The Testosterone Trials authors note that a much larger and longer trial would be needed to settle whether testosterone raises cardiovascular or prostate risk. That is why monitoring matters. The Endocrine Society guideline calls for aiming at mid-normal testosterone levels and following a standardized monitoring plan.
For the monitoring side, our posts on what to expect from clinician-led TRT and cholesterol changes on TRT cover follow-up labs in more depth.

What about women?
Most of the trials above enrolled men, so their findings should not be applied to women. Testosterone use in women is a separate topic with different dosing, routes and monitoring. If that is your question, start with our guides to testosterone for women and its side-effect checklist, and bring your own symptoms and history to a clinician.
Preparing for a consultation
A good visit starts with good information. Bring:
- A written list of mood symptoms: when they began, how often, and what makes them better or worse.
- Your sleep pattern, alcohol use, activity level and any recent weight change.
- All medications and supplements, including any antidepressants.
- Any past blood tests, especially testosterone, PSA and hematocrit.
- Family history of heart disease, prostate cancer or blood clots.
- Your goals, including fertility plans.
Questions worth asking:
- Could depression, anxiety, sleep apnea or another condition explain my symptoms?
- Do my labs meet the criteria for low testosterone, and have they been repeated?
- If I am treated, what mood change is realistic, and how will we measure it?
- Which formulations are FDA-approved, and which are compounded? Why was this one chosen?
- What follow-up labs will I need, and how often?
- When would we stop if it is not helping?
Our perspective
We think the most useful way to approach testosterone and mood is to start with measurement and a clinician conversation, not with a promise. The research supports modest benefit for some men with confirmed low levels, and that is a real reason to take symptoms seriously instead of dismissing them as stress or aging.
That is why we focus on the steps that make a decision informed: morning lab panels, a clinician review of symptoms and history, and a monitoring plan if treatment starts. Our site offers consultations, lab panels with home kits, and TRT and HRT membership options so that these steps can happen in one place. Whether treatment is appropriate is always the clinician's decision, and we would never suggest it replaces care for depression.
We also believe patients are better served when they know the difference between approved products, compounded preparations and investigational compounds. Ask about it at every visit.
AirMedFit
Taking the next step
If you want a clinician to look at your symptoms and labs, AirMedFit lists doctor consultation options on its site. The listing shows an Async Doctor's Consult at 49 USD and a Sync Doctor's Consult at 120 USD, each one-off. The Men's Essential lab panel with a home kit is listed at 129 USD. Confirm current availability, scope and follow-up on the page before you order, and note that a consultation does not guarantee a prescription.

You can also read how the telehealth TRT process works, or browse the full site at airmedfit.com.
FAQ
Can low testosterone cause depression?
Low testosterone is associated with depression, and some studies show higher odds of depression in men with the lowest levels. Association is not proof of cause, and many other factors affect both. A clinician can check whether low testosterone is present and whether depression needs separate treatment.
Does TRT improve mood?
In large trials of men with confirmed low levels, testosterone therapy was associated with modest average improvements in mood. Individual results vary, and the effect was not consistent for energy or vitality across studies. Ask your clinician how mood would be tracked if you start.
Can testosterone replace antidepressants?
No. Reviews describe testosterone as a complementary approach at best, under endocrinological supervision. Do not stop or change an antidepressant on your own. Talk with the clinician who prescribed it.
Is testosterone therapy approved for depression?
No. The FDA approves testosterone products for men with low levels due to certain medical conditions, not for depression or for low levels from aging alone. Any use beyond that is a decision for you and your clinician.
Sources
- Low Free Testosterone Concentration as a Potentially Treatable Cause of Depressive Symptoms in Older Men (JAMA Psychiatry, 2008)
- The effect of testosterone levels on mood in men: a review
- The role of testosterone, the androgen receptor, and depression (2022)
- Depressive Syndromes in Men With Hypogonadism in the TRAVERSE trial (JCEM, 2024)
- Effects of Testosterone Treatment in Older Men (NEJM, 2015)
- Lessons From the Testosterone Trials (2018)
- Association of Testosterone Treatment With Alleviation of Depressive Symptoms (JAMA Psychiatry, 2019)
- Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis (2017)
- Systematic Review of the Impact of Testosterone Replacement Therapy on Depression (2020)
- Testosterone and depression in men
- Psychiatric and Cognitive Effects of Testosterone Therapy (2026)
- Testosterone Therapy for Age-Related Low Testosterone (American Family Physician, 2021)
- Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Guideline (2018)
- FDA Drug Safety Communication on testosterone products
Recommended
- Clinician Led TRT for Men: Evidence, Realistic Benefits, and Safety Steps
- Testosterone Side Effects in Women: A Clinician Review Checklist
- Testosterone for Women: Dosage Ranges, Routes and Monitoring
- TRT and Fat Loss for Men: What the 2.9 kg Trial Means at Your Visit
This article provides general educational information and is not personalized medical advice. A licensed clinician should assess treatment suitability, risks, and options.
